structure of 1035555-63-5

(R)-3-(2,3-Dihydroxypropyl)-6-Fluoro-5-(2-Fluoro-4-Iodophenylamino)-8-Methylpyrido[2,3-D]Pyrimidine-4,7(3H,8H)-Dione(CAS 1035555-63-5)

CAS No.: 1035555-63-5 Brand: MolBest
M. Ft.: C17H15F2IN4O4 Cat. No: G1467930
M. Wt.: 504.23 MDL: No record
Storage: No record Use: For laboratory research use only
Purity Grade Package Stock Price Quantity
99%
Documents:COANMRSDS
RG 50MG In Stock 461 USD
Your region is eligible for ordering.
Should you have any questions, please contact us by Email.
Batch COA
Available
NMR Spectrum
Verified
In Stock
Fast Shipping
ISO 9001
Quality System

Promotion

Physical and chemical properties of 1035555-63-5

Acidity coefficient

13.72±0.20(Predicted)

Boiling Point

530.5±60.0 °C at 760 mmHg

Density

1.9±0.1 g/cm3

Exact Mass

504.010590

Flash Point

274.6±32.9 °C

Index of Refraction

1.710

LogP

0.28

Molecular Formula

C17H15F2IN4O4

Molecular Weight

504.227

PSA

109.38000

Storage condition

-20℃

Vapour Pressure

0.0±1.5 mmHg at 25°C

Download COA of 1035555-63-5

CAS/Product ID
*Required fields
Lot/Batch Number
*Required fields

Spectrums of 1035555-63-5

Attention:
1.The NMR spectrum displayed on the page is a pre-sale reference spectrum and may differ from that of the actual received batch.
2.The accompanying documentation will include the NMR spectrum and purity analysis data for the shipped batch.
Physical sample testing spectrum (NMR) of 1035555-63-5

Q&A for CAS 1035555-63-5

1. How can I verify product quality?
Every batch is tested in accordance with ISO 9001 requirements. We provide a Certificate of Analysis (COA), NMR spectrum, purity report, and test methods with each shipment. Third-party retesting is supported, and we offer a full refund if our data is incorrect.

2. What is the delivery time?
Orders are shipped on the second business day via FedEx, DHL, or UPS. International deliveries typically arrive within 7 business days (subject to customs clearance).

3. What if the received product doesn’t meet quality standards?
If the product does not match the COA or has a quality issue, we will issue a full refund or replacement upon verification.

4. Are hazardous labels included? How is safe shipping ensured?
Hazardous products are labeled and packaged in compliance with international regulations and shipped with an up-to-date Safety Data Sheet (SDS) to ensure safe and compliant transport.

5. Do you offer technical support?
Yes. Our technical team is available to assist with questions about product use, storage, purity requirements, applications, and more.

6. Are volume discounts available?
Yes. We offer competitive pricing for bulk orders. Please submit a quotation request, and we’ll provide a customized offer.

7. Do you provide samples?
Yes, samples are available for select products for testing and validation. Please submit a sample request or contact our sales team to confirm availability and specifications.

8. Do you have products in stock?
Items marked “In Stock” on our website are ready for immediate shipment, usually within 1–2 business days. Large packs or custom specifications require lead time confirmation.

9. Can you customize purity or packaging?
Yes. We support customization of purity, packaging size, and special testing requirements. Please share your detailed needs, and we’ll provide a solution.

10. Is the COA consistent with the shipped batch?
Yes. The COA provided with your shipment matches the actual batch and includes the batch number. COAs shown online are for reference or from previous batches.

11. Do you support long-term supply agreements?
Yes. We offer stable batch consistency, pricing agreements, and safety stock options for long-term customers to ensure uninterrupted supply.

12. What payment methods do you accept?
We accept bank transfer (T/T), PayPal, and other methods. Credit terms may be available for qualified long-term partners.

Applications of 1035555-63-5

TAK-733 is primarily explored for its applications in oncology:

  • Cancer Treatment: It is being investigated for use in treating advanced metastatic melanoma and other solid tumors characterized by aberrant MAPK signaling pathways.
  • Combination Therapies: Its ability to enhance the efficacy of existing chemotherapeutics makes it a candidate for combination therapy protocols aimed at overcoming drug resistance in cancer treatments.

Retrosynthesis analysis of 1035555-63-5

  • Route#1

    Cas:1035555-51-1
    Cas:1035555-63-5
  • Route#2

    Cas:1035556-26-3
    Cas:1035555-63-5
  • Route#3

    Cas:1227053-99-7
    Cas:1035555-63-5

Operate under the ISO 9001 system